Global Cancer Technology was formed to acquire a portfolio of various medical licenses for unique and promising patents and intellectual properties. The company has acquired licenses from the University of California, San Diego - John Moores Cancer Center and from the University of Washington. In addition, GCTholds an exclusive technology license from American Radiosurgery, Inc., an affiliated entity, to promote and sell high technology radiosurgery and cancer treatment products.
No articles found.
MyoPro is a powered orthosis (brace) that may help restore function in arms and ha...
MyoPro is a powered orthosis (brace) that may h...
Monogram Orthopaedics is attempting to refine a potentially revolutionary approach...
Monogram Orthopaedics is attempting to refine a...
Soliton, Inc. is a medical device company with a novel and proprietary platform te...
Soliton, Inc. is a medical device company with ...
Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing ...
Seres Therapeutics, Inc. is a microbiome therap...
Restance is pursuing several business lines in the growing economies of East Afric...
Restance is pursuing several business lines in ...
Since Aclaris was founded in 2012, our focus has been innovation to help people wi...
Since Aclaris was founded in 2012, our focus ha...
Establishment Labs is a global medical technology company focused on improving pat...
Establishment Labs is a global medical technolo...
Join the National Investor Network and get the latest information with your interests in mind.